Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Igor, Feldman"'
Autor:
Stephen Sazinsky, Mohammad Zafari, Boris Klebanov, Jessica Ritter, Phuong A. Nguyen, Ryan T. Phennicie, Joe Wahle, Kevin J. Kauffman, Maja Razlog, Denise Manfra, Igor Feldman, Tatiana Novobrantseva
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 6160 (2024)
V-set immunoglobulin domain-containing 4 (VSIG4) is a B7 family protein with known roles as a C3 fragment complement receptor involved in pathogen clearance and a negative regulator of T cell activation by an undetermined mechanism. VSIG4 expression
Externí odkaz:
https://doaj.org/article/33014c3e01f24cff8098a8c9257afb56
Autor:
Vivek Subbiah, Dmitriy Zamarin, Omid Hamid, Igor Feldman, Thomas Marron, Yuling Wu, Inderjit Mehmi, Michael Abadier, Analia Azaro, Anthony El-Khoueiry, Eduardo Castañón Álvarez, Jacky Chow, Praveen Aanur, Khanh Do, Vasudha Sehgal, Sandip P Patel, Benedito Carneiro, Linh Van, Nicholas Durham, Xiaoru Chen, Paula G Fraenkel, Arjun Oberoi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c2b5cd1235c14787ac32086337332951
Autor:
Wei Zheng, Jing Sun, Jeffrey Weber, Manish R Patel, Brandon Coder, Igor Feldman, Justin F Gainor, Jessica L Geiger, Martin Gutierrez, Joshua Frederick, Celine Robert-Tissot, Robert Meehan, Jack Pollard, Lakshmi Srinivasan, Michelle Brown, Kedar Kirtane, Julie E Bauman, Praveen Aanur, Jeffrey M Clarke, Ricklie A Julian, Aaron J Scott, Moomal Tasneem, Lauren Gerbereux, Andressa Laino, Peijie Hou, Vasudha Sehgal, Hikmat N Daghestani, Howard A Burris
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/ee729db4f6cb4ebfac2f821adca02921
Autor:
Phuong Nguyen, Igor Feldman, Mohammad Zafari, Ryan Phennicie, Veronica Komoroski, Steve Sazinsky, Joe Wahle, Denise Manfra, Tatiana Novobrantseva, Kathryn Rooney, Craig Mizzoni, Boris Klebanov, Jessica Ritter
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e697faf2efcc4f60b58a0a4e77f66798
Autor:
Phuong Nguyen, Igor Feldman, Mohammad Zafari, Ryan Phennicie, Kevin Kauffman, Dominika Nowakowska, Veronica Komoroski, Steve Sazinsky, Joe Wahle, Denise Manfra, Shantashri Vaidya, Michael Brehm, Tatiana Novobrantseva
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/b6379b7f4004491ab3e4d49d57c3f7b7
Publikováno v:
Advanced Biology.
Autor:
Stuart D. Shumway, D. Gary Gilliland, Stephen E. Fawell, Leigh Zawel, Carlo Toniatti, Yair Benita, Igor Feldman, Heather A. Hirsch, Brian Long, Alwin G. Schuller, Melissa S. Hurd, Yaping Liu, Jing Li, Amy D. Guertin
XLSX file - 155K, Proliferation assay EC50 results for MK-1775 in diverse tumor cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492fc6bcd867d365445a93212bebdc1b
https://doi.org/10.1158/1535-7163.22500334
https://doi.org/10.1158/1535-7163.22500334
Autor:
Scott A. Ribich, Heike Keilhack, Jesse J. Smith, Richard Chesworth, Robert A. Copeland, Peter Ho, John Campbell, Maria Roche, Kristy Kuplast-Barr, Sarah K. Knutson, Igor Feldman, Alexandra R. Grassian, Allison Drew, Kelli Armstrong, Elayne Chan-Penebre
The SWI/SNF complex is a major regulator of gene expression and is increasingly thought to play an important role in human cancer, as evidenced by the high frequency of subunit mutations across virtually all cancer types. We previously reported that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f0193e841ebe292cdd7fd3a4087a01
https://doi.org/10.1158/1535-7163.c.6537771.v1
https://doi.org/10.1158/1535-7163.c.6537771.v1
Autor:
Michael J. Thomenius, Alejandra Raimondi, Scott A. Ribich, Sarah K. Knutson, Elayne Chan-Penebre, Heike Keilhack, Robert A. Copeland, Jesse J. Smith, Christopher Plescia, Igor Feldman, Natalie M. Warholic, Vinny Motwani, Trupti Lingaraj, Allison Drew, Danielle Johnston-Blackwell, Dorothy Brach
The EZH2 small-molecule inhibitor tazemetostat (EPZ-6438) is currently being evaluated in phase II clinical trials for the treatment of non-Hodgkin lymphoma (NHL). We have previously shown that EZH2 inhibitors display an antiproliferative effect in m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16635ec96cb32a617f49970fa6370768
https://doi.org/10.1158/1535-7163.c.6539623.v1
https://doi.org/10.1158/1535-7163.c.6539623.v1
Autor:
Stuart D. Shumway, Andrew Bloecher, Theresa Zhang, Christopher Winter, Brian B. Haines, Razvan Cristescu, William Arthur, Andrey Loboda, Serguei Lejnine, Astrid Kral, Jing Li, Yaping Liu, Brian Roberts, Melissa Chenard, Igor Feldman, Yair Benita, Jennifer O'Neil
Supplementary figure, table and data legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462d5da00a1ff6efad42d8684cfdb08a
https://doi.org/10.1158/1535-7163.22503118
https://doi.org/10.1158/1535-7163.22503118